QuidelOrtho (NASDAQ:QDEL – Get Free Report) and Avita Medical (NASDAQ:RCEL – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.
Volatility & Risk
QuidelOrtho has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Comparatively, Avita Medical has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500.
Profitability
This table compares QuidelOrtho and Avita Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| QuidelOrtho | -14.24% | 3.22% | 1.03% |
| Avita Medical | -42.65% | N/A | -71.34% |
Earnings & Valuation
This table compares QuidelOrtho and Avita Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| QuidelOrtho | $2.73 billion | 0.27 | -$1.13 billion | ($5.41) | -1.99 |
| Avita Medical | $71.61 million | 6.86 | -$48.59 million | ($1.18) | -13.25 |
Avita Medical has lower revenue, but higher earnings than QuidelOrtho. Avita Medical is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current recommendations and price targets for QuidelOrtho and Avita Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| QuidelOrtho | 2 | 4 | 0 | 0 | 1.67 |
| Avita Medical | 1 | 1 | 5 | 0 | 2.57 |
QuidelOrtho presently has a consensus target price of $13.62, suggesting a potential upside of 26.86%. Avita Medical has a consensus target price of $16.60, suggesting a potential upside of 6.21%. Given QuidelOrtho’s higher probable upside, equities analysts plainly believe QuidelOrtho is more favorable than Avita Medical.
Insider & Institutional Ownership
99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 1.1% of QuidelOrtho shares are owned by company insiders. Comparatively, 2.2% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
About QuidelOrtho
QuidelOrtho Corporation develops and manufactures diagnostic testing products used in healthcare settings. Its offerings include tests and instruments for immunoassay, molecular diagnostics, clinical chemistry, and transfusion medicine, as well as rapid tests designed for point-of-care use. The company serves hospitals, clinical laboratories, blood banks, physician offices, and other healthcare providers. Its product lines include the VITROS clinical laboratory systems, ORTHO VISION blood-bank analyzers, and Sofia rapid diagnostic platforms.
About Avita Medical
AVITA Medical is a regenerative medicine company focused on treatments for skin restoration. Its flagship technology, the RECELL System, enables clinicians to use a small sample of a patient’s healthy skin to prepare a suspension of skin cells for application to wounds. The company’s RECELL products are used in the treatment of burns and certain other skin injuries, including full-thickness skin defects. The approach is intended to support wound coverage while reducing the amount of donor skin needed compared with conventional skin-grafting procedures.
Receive News & Ratings for QuidelOrtho Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuidelOrtho and related companies with MarketBeat.com's FREE daily email newsletter.
